Literature DB >> 23460708

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?

Susan M Domchek1, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23460708     DOI： 10.1200/JCO.2012.46.9403

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  99 in total

Review 1.  Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice.

Authors:  Jacquelyn M Powers; Jessica E Ebrahimzadeh; Bryson W Katona
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 2.  Familial colorectal cancer, beyond Lynch syndrome.

Authors:  Elena M Stoffel; Fay Kastrinos
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-17       Impact factor: 11.382

3.  Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.

Authors:  Cristi Radford; Anya Prince; Karen Lewis; Tuya Pal
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

Review 4.  Clinical applications of melanoma genetics.

Authors:  Michele Gabree; Devanshi Patel; Linda Rodgers
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 5.  Recent advances in Lynch syndrome.

Authors:  Leah H Biller; Sapna Syngal; Matthew B Yurgelun
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

6.  Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

Authors:  C L Scherr; N M Lindor; T L Malo; F J Couch; S T Vadaparampil
Journal:  Clin Genet       Date:  2015-02-26       Impact factor: 4.438

7.  Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.

Authors:  Veda N Giri; Elias Obeid; Sarah E Hegarty; Laura Gross; Lisa Bealin; Colette Hyatt; Carolyn Y Fang; Amy Leader
Journal:  Prostate       Date:  2018-04-14       Impact factor: 4.104

8.  The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.

Authors:  A E Bunnell; C A Garby; E J Pearson; S A Walker; L E Panos; Joanne L Blum
Journal:  J Genet Couns       Date:  2016-06-09       Impact factor: 2.537

9.  The evolution of cancer risk assessment in the era of next generation sequencing.

Authors:  Heather Fecteau; Kristen J Vogel; Kristen Hanson; Shannon Morrill-Cornelius
Journal:  J Genet Couns       Date:  2014-04-24       Impact factor: 2.537

10.  Cancer Genetic Counseling and Testing in an Era of Rapid Change.

Authors:  Gillian W Hooker; Keelia Rhoads Clemens; John Quillin; Kristen J Vogel Postula; Pia Summerour; Rebecca Nagy; Adam H Buchanan
Journal:  J Genet Couns       Date:  2017-04-22       Impact factor: 2.537
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.